Introduction-Reference-Cited by-同舟云学术

Introduction

Published:2010-12 Issue:3 Volume:11 Page:1-2
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Chapman M. John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference18 articles.

1. WHO. Cardiovascular diseases. World Health Organisation [serial online] 2010; Accessed May 5, 2010.

2. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet,2004

3. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study;O'Donnell;Lancet,2010

4. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);4S Study Group;Lancet,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to Cardiac Rehabilitation among Patients Diagnosed with Cardiovascular Diseases—A Scoping Review;International Journal of Environmental Research and Public Health;2024-03-13

2. Genetic Delivery and Gene Therapy in Pulmonary Hypertension;International Journal of Molecular Sciences;2021-01-25

3. Angiotensin (1-7) and Alamandine: Similarities and differences;Pharmacological Research;2016-09

4. Therapeutic agents for the management of atherosclerosis from herbal sources;Beni-Suef University Journal of Basic and Applied Sciences;2016-06

5. Triglycerides (TG) to High-Density Lipoprotein (HDL-c) Ratio (TG/HDL-c Ratio) as a Marker of Cardiometabolic Risk;Biomarkers in Cardiovascular Disease;2016